(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Effects of BMP and noggin application on the Wnt2b expression
pattern during early stages of eye development. (A) Schematic of a
stage 10/11 chick embryo showing the implantation site of the BMP5-soaked bead
in E. (B) At stage 13, Wnt2b transcripts are restricted to the
presumptive RPE (arrow). The arrowhead indicates Wnt2b expression in
the ectoderm. (C) Wnt2b transcripts are detected in the RPE
(arrows) and surface ectoderm (arrowhead) on the contralateral side of the
BMP5-treated eye shown in E. (D) Wnt2b expression in the
contralateral, untreated eye following implantation of noggin-expressing
cells. Wnt2b transcripts are restricted to the RPE (arrowhead) and no
transcripts are detected within the NR. The arrow shows Wnt2b
expression within the ectoderm and anterior lens. (E) Following BMP5
application (asterisk), Wnt2b expression is also detected in the
distal region of the optic vesicle, the presumptive NR (arrows). The arrowhead
indicates Wnt2b expression in the ectoderm. (F) Parallel
section of the noggin-treated eye shown in
Fig. 5B,D. Wnt2b
expression is downregulated in the entire outer optic cup (arrowheads). In the
surface ectoderm (arrow) and anterior lens, Wnt2b expression is still
detected.